Prescription drug · ANDA
Cefprozil NDC 0093-1078
Cefprozil 500 mg/1 · Tablet, Film coated · Oral · Teva Pharmaceuticals USA, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0093-1078-53 | 0009310785300093107853 | 50 TABLET, FILM COATED in 1 BOTTLE (0093-1078-53)Marketed from Dec 23, 2005 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Cefprozil
- Generic name (nonproprietary)
- cefprozil
- Active ingredients
- Cefprozil — 500 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- Teva Pharmaceuticals USA, Inc.NDC labeler code 0093
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 065208
- Marketing start
- Listing expires
- Identifiers
- Product ID 0093-1078_c226712f-00c2-407f-8b40-5ed1be54dfb8SPL ID c226712f-00c2-407f-8b40-5ed1be54dfb8SPL set ID 3391de8b-7bc9-4624-a5c4-836135b39d99RxCUI 197452, 197453UNII 4W0459ZA4V
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N400093107853followed by a unit qualifier and the quantityPackage 00093-1078-53. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Cefprozil tablets are indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below: UPPER RESPIRATORY TRACT Pharyngitis/tonsillitis caused by Streptococcus pyogenes . NOTE: The usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever, is penicillin given by the intramuscular route. Cefprozil is generally effective in the eradication of Streptococcus pyogenes from the nasopharynx; however, substantial data establishing the efficacy of cefprozil in the subsequent prevention of rheumatic fever are no…
Excerpt only. Read the full label for complete information.
About NDC 0093-1078
- What is NDC 0093-1078?
- 0093-1078 is the product NDC for Cefprozil, Cefprozil 500 mg/1 tablet, film coated, listed with the FDA by Teva Pharmaceuticals USA, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Cefprozil.
- What is the active ingredient?
- Cefprozil.
- Who is the labeler?
- Teva Pharmaceuticals USA, Inc., NDC labeler code 0093. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Cefprozil?
- 21 other product NDCs are listed under this name. See all Cefprozil NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Cefprozil products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Cefprozil | Cefprozil 250 mg/5mL | Powder, For suspensionOral | Lupin Pharmaceuticals, Inc. | 68180-273 | 68180-0273-0168180-0273-0268180-0273-03 |
| Cefprozil | Cefprozil 500 mg/1 | Tablet, Film coatedOral | Ascend Laboratories, LLC | 67877-243 | 67877-0243-50 |
| Cefprozil | Cefprozil 250 mg/1 | Tablet, Film coatedOral | Ascend Laboratories, LLC | 67877-244 | 67877-0244-01 |
| Cefprozil | Cefprozil 250 mg/1 | Tablet, Film coatedOral | NorthStar Rx LLC | 16714-398 | 16714-0398-01 |
| Cefprozil | Cefprozil 500 mg/1 | Tablet, Film coatedOral | NorthStar Rx LLC | 16714-399 | 16714-0399-01 |
| Cefprozil | Cefprozil 500 mg/1 | Tablet, Film coatedOral | A-S Medication Solutions | 50090-1710 | 50090-1710-00 |
| Cefprozil | Cefprozil 250 mg/1 | Tablet, Film coatedOral | Rising Pharma Holdings, Inc. | 57237-036 | 57237-0036-01 |
| Cefprozil | Cefprozil 500 mg/1 | Tablet, Film coatedOral | Rising Pharma Holdings, Inc. | 57237-037 | 57237-0037-0157237-0037-50 |
| Cefprozil | Cefprozil 250 mg/1 | Tablet, Film coatedOral | Aurobindo Pharma Limited | 65862-068 | 65862-0068-0165862-0068-0565862-0068-30+1 more |
| Cefprozil | Cefprozil 125 mg/5mL | Powder, For suspensionOral | NorthStar Rx LLC | 16714-396 | 16714-0396-03 |
Other NDCs under ANDA 065208
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Cefprozil | Cefprozil 250 mg/1 | Tablet, Film coatedOral | Teva Pharmaceuticals USA, Inc. | 0093-1077 |